Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Abstract: Zinc complex greases with different complexing acids having dropping points comparable to lithium greases and tailor-made dropping points can be made by processing at low temperature in open as well as close kettle process. The present invention discloses a process of manufacturing Zinc complex greases—through reaction of fatty acid and complexing acid with zinc oxide in mineral oil to obtain zinc complex greases having high dropping points of 180 to 280° C.

Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Abstract: A radiator includes a radiator frame, an array of tube assemblies each including a coolant tube and a tube clip supported in the radiator frame, and a lateral bump stop fitted between the array of tube assemblies and the radiator frame. The lateral bump stop includes cushions arranged in a staggered cushion pattern complementary to a staggered packing pattern of the tube assemblies with each of the cushions in contact with the tube clip of one of the tube assemblies.

Abstract: Zinc complex greases with different complexing acids having dropping points comparable to lithium greases and tailor-made dropping points can be made by processing at low temperature in open as well as close kettle process. The present invention discloses a process of manufacturing Zinc complex greases—through reaction of fatty acid and complexing acid with zinc oxide in mineral oil to obtain zinc complex greases having high dropping points of 180 to 280° C.

Abstract: A support assembly for attaching a heat exchanger to a frame of a machine. The support assembly including a clip having one or more attachment features for attaching to the frame and a support member disposed between a first fin portion and a second fin portion of the heat exchanger. The support member disposed between the clip and the tube member to at least partially surrounds a perimeter of the tube member and form a seal therewith.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: A radiator includes a radiator frame, an array of tube assemblies each including a coolant tube and a tube clip supported in the radiator frame, and a lateral bump stop fitted between the array of tube assemblies and the radiator frame. The lateral bump stop includes cushions arranged in a staggered cushion pattern complementary to a staggered packing pattern of the tube assemblies with each of the cushions in contact with the tube clip of one of the tube assemblies.

Abstract: A support assembly for attaching a heat exchanger to a frame of a machine. The support assembly including a clip having one or more attachment features for attaching to the frame and a support member disposed between a first fin portion and a second fin portion of the heat exchanger. The support member disposed between the clip and the tube member to at least partially surrounds a perimeter of the tube member and form a seal therewith.

Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: Disclosed are processes for preparation of spray dried powder and utilization as an ingredient in the preparation of fried bakery products particularly doughnuts and types thereof. This doughnut base powder is spray dried with emulsifiers and stabilizers to provide improved eating and keeping qualities of the doughnuts made thereof. This base powder includes fat from animal, vegetable, or dairy origin, emulsifiers, water soluble protein solids, salt, carbohydrates and stabilizers. The above compositions can be directly added with the flour, yeast or chemical leavening agents as well as supplemented with optional flavor, color and preservative to produce either an yeast raised or a cake doughnut with or without the utilization of eggs.

Abstract: The present invention relates to a spray dried 20-65% of natural mango pulp base powder which is composed of 21-55% of fat which can be used as an alternative to mango based desserts, soft serve ice creams and fillings. A functional fat filled natural mango powder comprise of 21-55% by weight of fat, 1-5% by weight of one or more proteins, 0.5-5% by weight of one or more emulsifier system, 1.5-2.0% by weight of buffers, 1-5% by weight of water and the balance is made up of non-starchy carbohydrates, antioxidants and stabilizers. Optionally flavor, color and anticaking agents can be supplemented to the composition. The above composition can be used directly or after reconstituted with water, to prepare foods such as desserts, fillings, mango shake. A functional fat filled natural mango powder can be conveniently used to develop processed food products such as soft serve ice cream, mango whipped toppings, mango mousse, mango puddings, kheer, custard, shrikhand, mango lassi.

Abstract: The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.